376 related articles for article (PubMed ID: 31927044)
21. Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer.
Philp L; Alimena S; Ferris W; Saini A; Bregar AJ; Del Carmen MG; Eisenhauer EL; Growdon WB; Goodman A; Dorney K; Mazina V; Sisodia RC
Gynecol Oncol; 2022 Feb; 164(2):421-427. PubMed ID: 34953629
[TBL] [Abstract][Full Text] [Related]
22. Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience.
Nagashima M; Ishikawa T; Asami Y; Hirose Y; Shimada K; Miyagami S; Mimura T; Miyamoto S; Onuki M; Morioka M; Izumi M; Yoshida R; Yamochi T; Taruno K; Nakamura S; Sekizawa A; Matsumoto K
Jpn J Clin Oncol; 2023 Jun; 53(6):472-479. PubMed ID: 36999211
[TBL] [Abstract][Full Text] [Related]
23. The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
Rudaitis V; Mikliusas V; Januska G; Jukna P; Mickys U; Janavicius R
Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():26-31. PubMed ID: 32059136
[TBL] [Abstract][Full Text] [Related]
24. Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
Ricciardi E; Tomao F; Aletti G; Bazzurini L; Bocciolone L; Boveri S; Landoni F; Lapresa MT; Maruccio M; Parma G; Peccatori F; Petrella MC; Zanagnolo V; Colombo N; Maggioni A
Anticancer Res; 2017 Sep; 37(9):5241-5248. PubMed ID: 28870960
[TBL] [Abstract][Full Text] [Related]
25. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
26. Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
Piszczek C; Ma J; Gould CH; Tseng P
J Minim Invasive Gynecol; 2018; 25(7):1179-1193. PubMed ID: 29097232
[TBL] [Abstract][Full Text] [Related]
27. Practice Patterns of Hereditary Ovarian Cancer Management in Korea.
Choi MC; Lim MC; Lee M; Kim MK; Suh DH; Song YJ; Kim TJ; Chang SJ; Kim JW
Int J Gynecol Cancer; 2017 Jun; 27(5):895-899. PubMed ID: 28498247
[TBL] [Abstract][Full Text] [Related]
28. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
Boerner T; Long Roche K
J Minim Invasive Gynecol; 2021 Mar; 28(3):403-408. PubMed ID: 33038519
[TBL] [Abstract][Full Text] [Related]
29. Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis.
Hermens M; van Altena AM; Bulten J; van Vliet HAAM; Siebers AG; Bekkers RLM
Fertil Steril; 2022 May; 117(5):938-945. PubMed ID: 35300832
[TBL] [Abstract][Full Text] [Related]
30. Physicians' Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women.
Jones NL; Schulkin J; Urban RR; Wright JD; Burke WM; Hou JY; McElwain CA; Tergas AI
Cancer Invest; 2017 Jan; 35(1):51-61. PubMed ID: 28029807
[TBL] [Abstract][Full Text] [Related]
31. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
32. Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients.
Oseledchyk A; Gemignani ML; Zhou QC; Iasonos A; Elahjji R; Adamou Z; Feit N; Goldfarb SB; Long Roche K; Sonoda Y; Goldfrank DJ; Chi DS; Saban SS; Broach V; Abu-Rustum NR; Carter J; Leitao M; Zivanovic O
Int J Gynecol Cancer; 2021 Feb; 31(2):222-231. PubMed ID: 33273020
[TBL] [Abstract][Full Text] [Related]
33. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
[TBL] [Abstract][Full Text] [Related]
34. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Steenbeek MP; van Bommel MHD; Harmsen MG; Hoogerbrugge N; van Doorn HC; Keurentjes JHM; van Beurden M; Zweemer RP; Gaarenstroom KN; Penders CGJ; Brood-van Zanten MMA; Vos MC; Piek JM; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; IntHout J; de Hullu JA; Hermens RPMG
Gynecol Oncol; 2021 Nov; 163(2):371-377. PubMed ID: 34456057
[TBL] [Abstract][Full Text] [Related]
36. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
37. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
Miller H; Pipkin LS; Tung C; Hall TR; Masand RP; Anderson ML
J Minim Invasive Gynecol; 2017; 24(5):772-776. PubMed ID: 28285055
[TBL] [Abstract][Full Text] [Related]
38. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
39. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
Powell CB; Kenley E; Chen LM; Crawford B; McLennan J; Zaloudek C; Komaromy M; Beattie M; Ziegler J
J Clin Oncol; 2005 Jan; 23(1):127-32. PubMed ID: 15625367
[TBL] [Abstract][Full Text] [Related]
40. Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.
Kim SI; Lim MC; Lee DO; Kong SY; Seo SS; Kang S; Lee ES; Park SY
J Cancer Res Clin Oncol; 2016 Jan; 142(1):333-40. PubMed ID: 26438354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
